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Angiotensin II control of the renal microcirculation: effect of blockade
by saralasin. The hydronephrotic rat kidney with intact circulation and
innervation was split and spread out as a thin sheet in a tissue bath. The
microvasculature was observed in vivo via television microscopy. We
quantitated the effects of increasing concentrations (l0 to l0— M) of
saralasin (angiotensin II antagonist) applied locally in the tissue bath on
microvascular diameters and on relative glomerular blood flow (mea-
sured using fluorescent labeled RBCs). Saralasin produced an increase
in preglomerular diameters which was largest (37 11%) in the in-
terlobular artery (there was no dilation in the afferent arteriole near the
glomerulus), an increase in postglomerular diameters which was largest
(17 4%) in the efferent arteriole near the glomerulus, and an increase
in blood flow (19 4%). If these types of findings would hold for the
normal kidney, it would suggest a role for angiotensin II in the control
of total renal blood flow, in the regional distribution of flow, and in the
control of filtration fraction. We also made control micropressure
measurements using the servo-nulling approach. Pressures measured
were: afferent arteriole, 65 5 mm Hg; intraglomerulus, 50 5 mm Hg;
and efferent arteriole, 19 3 mm Hg. These data indicate that there is
major vascular resistance near the glomerulus, especially in the efferent
arteriole.
The effects of angiotensin II and of angiotensin II blockade on
renal blood flow, glomerular filtration rate and filtration fraction
have been extensively studied. In general, there is agreement
that angiotensin II plays a role in the control of renal function;
however, there is major controversy over the nature of this role
and the site of action. [1]
Several studies indicate that angiotensin II gives constriction
of both preglomerular and postglomerular vessels [1—5]. Blantz
[11 showed in the Munich—Wistar rat that infusion of angioten-
sin II gave a parallel increase in both single nephron preglomer-
ular and postglomerular vascular resistances. Click, Joyner,
and Gilmore [2] looked at renal tissue that had been trans-
planted to the hamster cheekpouch and found that topical
application of angiotensin II caused constriction of both the
afferent and efferent arterioles. Navar et a! [6] found that
converting enzyme inhibitor decreased both preglomerular and
postglomerular resistance in the sodium depleted dog. Finally,
Tucker and Blantz [5] found that activation of tubulo-glomer-
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ular feedback by benzolamide gave an increase in both preglo-
merular and postglomerular resistances, which could be totally
blocked by saralasin (a specific antagonist of angiotensin II).
A number of other studies suggest that only postglornerular
vessels, not preglomerular vessels, are involved in angiotensin
II control of the renal microcirculation [7—131. Edwards [8]
looked at the responses of isolated rabbit interlobular arteries
and afferent and efferent arterioles to angiotensin II and found
that only efferent arterioles responded. It should be noted that
the ends of these vessel segments, including the sections
adjacent to the glomerulus, were held by pipettes and, thus,
were not observed. A number of the studies used isolated
perfused kidneys [7, 9, 12, 131 found that infusion of angiotensin
II produced increases in glomerular filtration rate and filtration
fraction, which were interpreted as indicating that the primary
effect of angiotensin II is constriction of the postglomerular
vessel. Hsu, Kurtz, and Slavicek [101 found that in the awake
rat, angiotensin Ii infusion gave an increase in filtration frac-
tion. They also used a microsphere technique to measure the
diameter of the afferent arteriole and found no change in the
diameter with angiotensin II infusion and, thus, concluded that
the total effect was on the efferent arteriole.
Finally, a single study [14] using saralasin in the sodium—
depleted rat suggested that the entire effect of angiotensin II is
in the preglomerular vessels with no effect in the postglomerular
vessels. Thus, the site of action of angiotensin II in the kidney
is still an open question. As Edwards pointed out recently [81,
"One of the major reasons for this uncertainty is the inacces-
sibility of the various segments of the renal microvasculature
for direct study." In the intact kidney, one is only able to
observe the microcirculation in the glomerular loops, at the
welling point (the branching point of the efferent arteriole), in
the peritubular capillaries, and in some structures of the open
papilla.
To overcome this problem and to allow direct visualization of
a number of vascular levels, we have developed a new renal
model in the rat [15]. With this method, unilateral hydronephro-
sis is induced over three to four months. The kidney becomes
greatly enlarged and fluid—filled and the renal parenchyma is
compressed into a thin layer just under the capsule. The tubular
system of the hydronephrotic kidney is nearly destroyed,
whereas the vascular system in many regions appears to be
intact. In acute experiments, the hydronephrotic kidney can be
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split along its axis and spread as a thin sheet in a tissue bath to
allow for direct in vivo observation of the microcirculation.
Thus, it is possible to observe the kidney under controlled
conditions and to measure changes in vascular diameters and
blood flow with both local and systemic drug applications.
In this study, we quantitated the dose—response effects of
local application of saralasin on the diameters of a number of
renal mierovaseular levels and on relative glomerular blood
flow (measured with fluorescence—labelled erythrocytes), Fi-
nally, micropressures were measured in the afferent and ef-
ferent arterioles and in the glomerulus,
Methods
For these studies, 28 female Wistar—Furth rats, weighing 175
to 225 g were used. Our surgical technique is described in detail
in an earlier paper [15]. Basically, unilateral hydronephrosis
was produced by permanently ligating the left ureter via a flank
incision while the animals were anesthetized with pentobarhital
(NembutalR, 60 mg/kg). To accelerate the development of
hydronephrosis, the left renal artery was clamped for one hour
during the same operation. The rats were maintained in an
animal care facility for three to four months after the renal
surgery to allow for the development of hydronephrosis, and
then acute microcireulation studies were performed during
thiobutalbarbital anesthesia (Inactine', BYK, 100 mg/kg, i.p.).
The animals were tracheotomized and body temperature was
kept at 37.0 to 37.5°C by a temperature—regulated operating
table. The left carotid artery was cannulated for continuous
measurement of arterial blood pressure control. The jugular
vein was eannulated for continuous infusion of isotonic saline at
0.06 mliter/min and the femoral artery was eannulated for
collection of blood samples.
The hydronephrotie left kidney was exposed by a flank
incision and split with a cutting cautery along its greater
curvature. The ventral part of the kidney was spread out as a
thin sheet and attached to an oval—shaped wire form with
atraumatic sutures. The kidney was then positioned in a
plexiglass bath which had a notch in the side for the renal hilus.
The notch was closed with a high viscosity silicon grease (which
did not compress the blood vessels) and the bath was filled with
80 mliter of an isotonic and isocolloidal solution (HcmaeeelR)
which was maintained at 37.0 to 37.5°C by an automatic heating
system.
The bath approach allowed for microscopic examination of
the renal microcireulation by both transillumination and epiil-
lumination. We used the Leitz-UO-55 Water Immersion Micro-
scope, combined with the Leitz—Ploemopac—System for fluo-
rescence microscopy. The microscopic image was observed by
a closed—circuit television system and was recorded on video-
tape. Vascular diameters were measured by direct visualization
from the monitor screen. Vascular levels studied were:
interlobar a., proximal arcuate a. (near its branch from the
interlobar a.), distal arcuate a. (near the interlobular a.),
interlobular a., proximal afferent a. (near the interlobular a.),
distal afferent a. (20 to 60 jim from the glomerulus), proximal
efferent a. (20 to 60 jim from the glomerulus) and distal efferent
a. (at the welling point).
To quantitate a relative index of blood flow, we injected
fluorescent—labelled erythrocytes [16] in an amount which al-
lowed us to count the number passing through the glomerulus
per unit of time. Percentage changes in this number were then
considered to be percentage changes in blood flow. To visualize
the fluorescent—labelled erythroeytes we used a high sensitivity
camera (Siemens—Restlieht Camera, model K SB) and strobo-
scopic illumination (Chadwick—Helmuth Company, Inc., El
Monte, California, USA) in combination with heat filters,
blue—green fitter 38, a UV-filter (Schott, Mainz, FRG), and an
interference filter which gave a wave—length maximum of 490
nm. In addition, the emitted light was passed through a 530 nm
filter [171.
Micropressures in the afferent and efferent arterioles and in
the glomerolus were measured using the resistance servo-
nulling technique of Wiederhielm [18, 19] as modified by
Intaglietta [201. Mieropipets with tip diameters of I to 7 jim
were positioned with a micromanipulator. Intraluminal pres-
sures in the afferent and efferent arterioles were obtained by
puncturing the vessels at a distance of 20 to 60 jim from the
glomerulus. Glomerular pressures were measured by inserting
the micropipet in the center of the glomerulus. Care was taken
to cause minimal damage on entry. The exact position of the
mieropipet tip could not be determined in these experiments
and, thus, we do not know if the pressures measured were intra-
or extra-glomerular capillary pressures. Our assumption is that
the pressure drop across the capillary wall is small and,
therefore, the error introduced by our uncertainty is also small.
In any event, if there is error it is in the direction of underes-
timating glomerular capillary pressure.
Two major series of experiments were completed for both
diameter and erythrocyte flux measurements. The first series
was control (no drug) experiments which looked at the stability
of our preparation, and the second series was the responses to
blockade of endogenoos angiotensin by saralasin. All experi-
ments were divided into ten mm periods. Measurements of
vessel diameters and red cell flux (for some experiments) were
made in the last five mm of each ten mm period. One to three
measurements for diameters (at each vessel level) and red cell
flux were made in each period. These measurements were
averaged to give a single value for each period and these
averaged values were used for later statistical analysis. There
were usually five to ten mm intervals between the ten minute
periods. The first three, ten minute periods were normally for
control measurements. For the saralasin experiments, saralasin
was added to the bath at the beginning of the fourth period to
give a concentration in the bath of l09M. At the beginning of
each successive period, progressively larger concentrations of
saralasin were added to the bath until a concentration of I05M
was reached. The protocol for the no—drug experiments was
simply ten, tn minute control periods.
In an additional series, micropressure measurements were
made. Some of these measurements were made in separate
experiments and some were made following the above proto-
cols (after replacing the tissue bath solution with fresh solution
and allowing a prolonged recovery period). No differences in
pressure measurements were seen for the two approaches, and
so the data were combined.
For analysis of the diameter data and red cell flux data, (-tests
were used to compare values in the individual periods to the
control values, Significance was set at the P < 0.05 level.
58 Steinhausen et at
Table 1. Control vascular diameters (sm).
Interlobar 56.8 4.0
Arcuate a—proximal 41.0 2.0
Arcuate a.—distal 21.7 2.2
Interlobular a. 12.0 2.1
Afferent a—proximal 9.9 0.8
Afferent a—distal 8.5 1.1
Efferent a—proximal 10.9 0.7
Efferent a.—distal 15.9 1.1
Saralasin
+40 i09 M 10-8 M iO- M
+20
01+
Preglomerular
Postglomerular
Results
Mean arterial blood pressures throughout the experiments for
all rats averaged 116 2 mm Hg. The pressures were stable for
the duration of the experiments, and there was no evidence of
an uptake of saralasin by the exposed kidney vasculature
having a systemic cardiovascular effect. Table I gives control
vascular diameters for the saralasin experiments.
Topically applied saralasin produced a dose—dependent dila-
tion at all vessel levels except the interlobar a. and the distal
afferent a. (Fig. 1). At the highest dose (105M saralasin), the
largest dilation was seen in the interlobular a. (37 11%). On
the preglomerular side, the response grew progressively smaller
at locations both proximal and distal to this level. It is interest-
ing that the proximal end of the afferent a. dilated by 22 9%,
but the distal end of the same vessel, some 100 to 200 pm
downstream, showed no dilation. On the postglomerular side,
the proximal efferent arteriole gave a significant dilation to the
three highest doses of saralasin. In the no—drug experiments
there was no significant change in diameter at any vessel level
at any time.
In three preliminary experiments we tested the angiotensin II
blockade by saralasin. With saralasin (105M) in the bath, a high
dose of angiotensin II (I06t) was added to the bath. This dose,
which gave large constriction of the afferent and efferent
arterioles in the absence of saralasin, gave no response with
saralasin present.
+ri+1
Saralasin concentration
Fig. 2. Red cell flux (relative index of blood flow) with progressive
increases in saralasin concentrations in the kidney tissue bath. Values
for each 10-minute period are expressed as percent of the initial control
values. Asterisks indicate P < 0.05 for the change from the initial
control, numbers in the bars are number of animals.
Flux of fluorescent labelled red blood cells through the
glomerulus (as an indication of blood flow) is shown for the
response to saralasin (Fig. 2). The absolute number of red cells
passing through the glomerulus per unit of time was dependent
on the number injected and on the volume of distribution as well
as on the flow; thus, the data are expressed as a percent of
control. With the application of saralasin there was an increase
in red cell flux which reached a maximum of 19 4% with the
highest dose of saralasin. The ED50 for red cell flux was
between i— and l06M. We observed no change in the
diameter of the whole glomerulus or in the diameter or config-
uration of individual glomerular capillaries after the topical
application of high concentrations of saralasin, or of concentra-
tions of angiotensin II, which constricted the afferent and
efferent arterioles completely. In the control experiments, there
were small variations in flux, but no significant changes.
The results of the micropressure series are given in Figure 3.
These measurements were taken under control conditions. For
the five animals in which afferent arteriole pressure was mea-
sured, the pressure dropped from ill 6 mm Hg (carotid
artery pressure) to 65 5 mm Hg in the afferent arteriole (a
drop of 41% of total MAP). The pressure dropped further to 50
5 mm Hg within the glomerulus (14% drop) and finally to 19
3 mm Hg in the efferent arteriole (28% drop).
Discussion
When a new model is used, especially one that involves a
pathology, the validity of the model is always a question. For
the present study, hydronephrosis was simply used as a tool to
produce a tissue which was thin enough for transilluminated in
vivo microscopy. This thin tissue allowed vascular structures
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Fig. 1. Vascular diameter responses to progressive increases in
saralasin concentration in the kidney tissue bath. Diameters for each of
the ten minute exposure periods are expressed as percent of the initial
control values. The brackets are 1 SEM and asterisks indicate P < 0.05
for the change from control (N = number of animals).
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Fig. 3. Micropressure measurements (mm Hg) during control condi-
tions in the afferent and efferent arterioles and within the glomeralas.
Numbers in the bars are number of animals.
which normally can't be seen to be clearly visible. Data
obtained for these structures were quite interesting, but any
extrapolation to the normal kidney must be done with great
caution and reservation.
Microscopic observation of the tissue revealed a rich vascu-
lar network with brisk flow in most areas. Preliminary studies
indicated that the vasculature had appropriate responsiveness
to a variety of vasoactive agents. There was a reduction in
blood flow with hydronephrosis [15], but previous workers have
shown that alterations in the blood vessels were only minor
[21—23]. Also, using an electron—micrographic approach we saw
no changes in glomerular capillaries [15]. Finally, we [241
recently completed a study which begins to anatomically and
histochemically characterize the model. We found the kidney to
be a fibrous tissue sheet of 150 to 300 m thickness. The
integrity of the vasculature was maintained, and ultrastructural
examination showed the organdIes in vascular smooth muscle
to be unchanged. Numerous intact sympathetic axon terminals
were found. Immunocytochemical staining for renin showed no
change in the renin distribution with the development of hydro-
nephrosis. Total renin content of the kidney was also found to
be unchanged.
With topical application of saralasin, we found dilation in
preglomerular vessels from the proximal arcuate a. to the
proximal afferent a. Dilation was maximal in the interlobular a.
and then decreased in magnitude both proximally and distally to
the point that there was no response in the interlobar a. or the
distal afferent a. It is interesting to note that angiotensin II
control was so localized that one segment of the afferent a. was
partially constricted by angiotensin II, but that a few hundred
microns away in the same vessel there was no constriction. In
the postglomerular vessels there was large dilation in the
proximal efferent a. and much small dilation in the distal
efferent a. Thus, in this preparation there appear to be two foci
of endogenous angiotensin II activity. One was preglomerular
at some distance from the glomerulus and the other was
postglomerular and very near to the glomerulus,
Other workers, using local application of angiotensin II [21
and converting enzyme inhibitor [6], have suggested that an-
giotensin 11 has both preglomerular and postglomerular effects.
A number of other studies [1, 3, 4, II, 251 have found that
angiotensin II infusion increases both preglomerular and
postglomerular resistance. The interpretation of these experi-
ments with angiotensin II infusion is complicated by the in-
crease in systemic arterial blood pressure that occurs with the
infusion. The increase in blood pressure could cause reflex
constriction of the preglomerular vessels. The present study
avoids some of these problems. Our topical application of
saralasin (which causes no change in systemic blood pressure)
demonstrated that for our model there is local angiotensin
IT—induced constriction in both preglomerular and postglomer-
ular vessels.
A number of studies report only a postglomerular effect of
angiotensin II [7—13, 26, 271. Ichikawa, Miele and Brenner [11]
infused very low doses of angiotensin II (which caused no
change in system blood pressure) directly into the renal artery
and found only an increase in postglomerular resistance.
Blantz, Konnen and Tucker [251 infused a slightly higher dose
of synthetic angiotensin II, which increase blood pressure by
only 10 mm Hg and found that, in addition to the increase in
postglomerular resistance, there was considerable increase in
preglomerular resistance. In our earlier study with the hydro-
nephrotic kidney [151, we found that angiotensin II infusion at
low doses gave constriction of the efferent arteriole, but at
higher doses gave constriction of both the afferent and efferent
arterioles. These combined studies suggest to us that angioten-
sin II can directly constrict both preglomerular and postglo-
merular vessels, but that in some situations the postglomerular
vessels are more sensitive.
Comparison of the data in Figure 2 and in Figure 3 show that
the increase in blood flow with kidney exposure to increasing
concentrations of saralasin roughly parallel the vascular dila-
tions. This observation suggests that the dilations observed
were responsible for the increase in flow. There could, of
course, be angiotensin TI—induced constriction in the larger
renal vessels that we did not study. We do, however, think that
our finding that the angiotensin II effect is seen to decrease as
one moves upstream to the point that there is no effect in the
proximal areuate a. makes it likely that the major angiotensin II
effects are in the vessels that we studied.
Our data, which showed no response to saralasin at several
vascular levels (interlobar a. and distal afferent a.), raise the
question of the ability of these vessel areas to respond to
angiotensin II. In preliminary experiments for this study, we
were able to produce constriction in the distal afferent a. by
adding angiotensin II locally to the tissue bath. (We did not
study the interlobar a. in these preliminary experiments.) This
constriction could be completely blocked by addition of
saralasin to the tissue bath. Thus, this vascular level can
respond to angiotensin II, but apparently at control conditions
in our model, the area was simply not exposed to a high enough
concentration of angiotensin II to induce the constriction.
Our general interpretation of these vascular diameter re-
sponse data and flow data is that there is angiotensin II control
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focused at two locations in the renal microcirculation. One
location is preglomerular and one is postglomerular. The overall
control at both locations could combine to give a type of total
flow control with most of this residing in the preglomerular
vessels. The preglomerular site is also well located to give some
control of flow distribution.
The importance of an angiotensin II effect on the
postglomerular side could involve control of filtration fraction.
Some studies [7, 10, 12, 131 have found that angiotensin II
infusion gives an increase in filtration fraction. They suggested
that angiotensin II was acting by constricting the efferent
arteriole, which would in turn increase glomerular capillary
pressure and hence, would increase glomerular filtration rate.
Such an action could protect renal function in the face of
decreased blood pressure. Hall, Guyton and Cowley (26, 27)
found evidence ofjust such a mechanism in the dog. When renal
artery pressure was decreased by 30 to 40 mm Hg, they found
little or no change in glomerular filtration rate. However, when
the same experiment was repeated in the presence of an
angiotensin antagonist or in a renin depleted dog, there was a
large drop in glomerular filtration rate. Our model using the
hydronephrotic kidney is, of course, nonfiltering; however, our
data are totally consistent with such a role for the postglomer-
ular vessels (that it, filtration fraction and hence, glomerular
filtration rate being regulated via the renin—angiotensin system).
A number of studies [9, 26, 28—301 have suggested that there
is production of angiotensin II in the kidney. Frega, Davalos
and Leaf [91 demonstrated that renin substrate infusion in the
isolated rat kidney gives an increase in filtration fraction which
can be blocked by an angiotensin 11 antagonist. Burghardt,
Schweisfurth and Dahlheim [29] in their study on rats con-
cluded that "All is probably synthesized at a high rate in
glomerular structures." This site of production of angiotensin II
would allow for different concentrations of angiotensin to be
seen by the preglomerular and postglomerular vessels, and also
allows for separation of the control of their functions.
Our values for afferent and efferent arteriole diameters (about
10 m) are similar to the values that we found in our previous
study using the hydronephrotic model [15]. Our values, how-
ever, are smaller than those suggested by studies using the
intravascular injection of 15 m microspheres [31—331. In gen-
eral, these studies found that the microspheres lodged in the
glomerular capillaries and, thus, it was concluded that the
afferent arterioles are at least 15 tm in diameter. We have
recently conducted preliminary experiments with our prepara-
tion using injections of 15 rm microspheres. We found that
when these microspheres were flushed into the arterial supply
of the kidney, most became lodged in the glomerular capillaries.
On several occasions, we microscopically observed the glomer-
ulus while microspheres were injected. We saw individual
microspheres transiently stop in the afferent arteriole and then
move into the glomerulus. This would appear to be the result of
either the pressure—head pushing the microspheres through the
very distensible vessels or it was myogenic vasodilatation of the
afferent arteriole following the large pressure drop which would
occur when the vessel became occluded.
Intraglomerular pressure in our experiments (our estimate of
glomerular capillary hydrostatic pressure) was measured as 50
5 mm Hg. This values is in very good agreement with the
literature for the normal (non-hydronephrotic) rat kidney [1,
34]. We also measured intraluminal blood pressure in the
afferent and efferent arterioles at a distance of 20 to 60 m from
the glomerulus. The pressure drop along the length of the
glomerular capillaries was very small—probably 1 to 2 mm Hg
[1]. Therefore, nearly all of the pressure drop that we saw must
be in the short segments of the vessels near the glomerulus.
This means that the pressure dropped about 14 to 15 mm Hg in
the last 20 to 60 m of the afferent arteriole, and that it dropped
about an additional 30 to 31 mm Hg in the first 20 to 60 tm of
the efferent arteriole. Casellas and Navar [34] are the only other
workers to measure intraluminal pressures in the afferent and
efferent arterioles. Their preparation was very different than
ours. They also found large pressure drops in these vessels, but
they actually recorded a larger drop in the afferent arteriole than
in the efferent arteriole.
In our first study with the hydronephrotic kidney preparation
F 15], we noted that both vessels (afferent and efferent arterioles)
had markedly narrowed segments immediately adjacent to the
glomerulus. These narrowings would be points of high resist-
ance to flow and were probably responsible for most of the
pressure drop that we saw in the present study. The narrowing
was most obvious in the efferent arteriole, where we found the
larger pressure drop, and at this point there appears to be a
specialized round cell which looked like it could act as a
sphincter [15]. This narrowing of the efferent arteriole has been
seen by other workers in the normal kidney of the rat [35] and
rabbit [8]. Evans and Dail [35] have speculated that the narrow-
ing is the major regulator site for controlling vascular resistance
in the entire efferent arteriole. Systematic study of this nar-
rowed area, which has not yet been done, is needed to clarify its
function. This will be difficult, however, because the small
changes in diameter, which would give large changes in resist-
ance, are difficult to visualize.
In conclusion, we found two foci of angiotensin II control in
our hydronephrotic preparation of the renal microcirculation—
one preglomerular and one postglomerular. If these vascular
characteristics hold for the normal kidney, they may point to
angiotensin 11 involvement in total flow, flow distribution con-
trol in the preglomerular vessels, and filtration fraction control
in the postglomerular vessels. Finally, there are large drops in
intraluminal pressure in the segments of the afferent and ef-
ferent arterioles which are adjacent to the glomerulus. Nar-
rowed areas of the vessels, which are most prominent in the
efferent arteriole, are probably responsible for most of the
pressure drop and may have a specialized function.
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